Annual Report 2008
Multiple Myeloma Research Foundation
The mission of the MMRF
is to relentlessly pursue
innovative means that
accelerate the development
of next-generation multiple
myeloma treatments to
extend the lives of patients
and lead to a cure.
MissionStatement
The Mu l t i p l e Mye loma Re s ea rch
Foundation (MMRF) was founded in 1998
by identical twin sisters Kathy Giusti
and Karen Andrews following Kathy’s
diagnosis with multiple myeloma.
Since its inception, the MMRF has
remained committed to breaking
down the barriers s lowing medical
research and drug development. It has
raised more than $115 million for multiple myeloma research,
funded more than 90 research institutions, developed a diverse
research portfolio to deliver better treatments to patients faster,
and built a collaborative research model, the Multiple Myeloma
Research Consortium (MMRC), that is transforming the drug
development process from one that produces results in decades to
one that produces results in a few years.
The work of the MMRF contributed to the FDA approval of four
drugs that have helped almost double life expectancy in some
patients. Because of their success in myeloma, these same drugs are
now being explored as potential treatments for more than 20 other
cancers and diseases. Today the MMRF is funding research into 30
compounds and combination approaches that may represent the
next generation of treatments and is supporting the advancement
of high-priority clinical trials of novel compounds and combination
approaches through the MMRC.
A b o u t t h e
MMRF
MMRF Co-Founders Kathy Giusti and Karen Andrews
Dear Friends,
With you by our side, the Multiple Myeloma Research Foundation (MMRF) is
making a real difference in the lives of multiple myeloma patients and their
families. We have reached incredible milestones in 2008 that are helping
patients live longer lives.
Thanks to your support, in 2008 we:
Initiated 7 new trials of novel and combination treatments through the Multiple
Myeloma Research Consortium (MMRC)
Supported more than 30 compounds and approaches in clinical trials and
pre-clinical studies
Made incredible progress in advancing the Multiple Myeloma Genomics
Initiative – bringing us one step closer to the promise of personalized medicine
for multiple myeloma
I know you are just as excited as I am about the progress we are making. But, in an environment
where funding for biomedical research is diminished and the next new treatments for multiple
myeloma are not expected to be available until 2011, we must work more urgently than ever to
rapidly advance our research portfolio and immediately bridge this gap.
Because of your renewed and dedicated support, we are able to maintain our barrier-breaking
momentum and ensure that the next lifesaving treatment will be there when a patient needs it.
Thank you for your commitment and generosity.
Warmest regards,
Kathy Giusti
Founder and Chief Executive Officer
MMRF Annual Report 2008 3
Report from theChief Operating Officer
Dear Friends,
In these uncertain economic times, it is more importantthan ever that your donation is invested wisely and responsibly.As one the most efficient and effective charities worldwide,the Multiple Myeloma Research Foundation (MMRF) iscommitted to maximizing each dollar raised, directingan outstanding 93 percent of all funds raised toward itsinnovative research portfolio and related programming.
We have been and always will be a leader in fiscal responsibility. This year, ourexceptional financial management resulted in us reaching several importantmilestones, including:
$115 million raised to date to support cutting-edge multiple myeloma research and drug development
$14 million invested in our research portfolio’s high-priority research programs
A 4-star rating from Charity Navigator for the sixth consecutive year, a ranking that places us among the top two percent of all charities
You can be certain that we make the most of your donation and that your dollarsdo make a difference.
Thank you for support and for your belief in our mission.
Scott SantarellaCOO and Executive Director
Scott SantarellaCOO and Executive Director
4
As a good steward of your donation, the Multiple Myeloma Research Foundation (MMRF) directs anoutstanding 93 percent of contributions toward research and related programming. The MMRF hasconsistently earned top rankings from the nation’s leading charity evaluators for its fiscal responsibility.
An A+ from the American Institute of Philanthropy
A 4-star rating from Charity Navigator
“Best in America” Seal of Excellence from the Independent Charities of America
Complies with the Better Business Bureau’s (BBB) Wise Giving Alliance Standards forCharity Accountability
Approval from the National Cancer Institute (NCI) for our research grants program
The MMRF is the world’s only organization to have received these exceptional accreditations.
2008 Allocation ofMMRF Funds
4% Fundraising
3% Administrative Costs
93% Research Awards and Related Programming
ExceptionalFinancial Management
MMRF Annual Report 2008 5
Accelerating the Delivery of New Treatments
6
The Multiple Myeloma Research Foundation (MMRF) makes the most of your investment bysupporting one of the world’s most strategic and aggressive research and drug developmentportfolios. Our innovative portfolio is comprised of cutting-edge research programs in three paths —basic science, validation, and clinical trials — that represent our long-, mid-, and short-term strategyto deliver to patients the next generation of treatments. With a pay-line averaging 25 percentcompared with the National Cancer Institute’s pay-line of less than 15 percent, we make surethat no high-priority research program goes unfunded.
In 2008, the MMRF directed nearly $14 million toward its innovative research portfolio.
Basic ScienceAccelerating Personalized Medicine
Through our basic science research programs, researchers are learning more about the genes, proteins,and molecular pathways that play a role in the onset and progression of multiple myeloma and areusing that information to better understand which patients will benefit from which treatments.
Multiple Myeloma Genomics Initiative
In 2008, the Multiple Myeloma Genomics Initiative, a comprehensive genome-mapping programconducted in partnership with the Translational Genomics Research Institute (TGen) and theEli and Edythe L. Broad Institute, completed comprehensive analyses of 200 patient tissuesamples. These analyses are helping to identify potential new therapeutic targets for the disease andposition the Initiative to be the first to complete whole genome sequencing in 200 patients.Findings from the Multiple Myeloma Genomics Initiative were presented in oral presentations atthe American Society of Hematology’s (ASH) 50th Annual Meeting and Exposition, and at theAmerican Association of Cancer Research (AACR).
“The Multiple Myeloma Genomics Initiative is critical to
advance personalized medicine in myeloma — helping
us to better understand how to match the right patient
to the right drug at the right time.”
– Todd Golub, MD, Broad Institute of MIT and Harvard
“It gives me tremendous
h o p e t o k n o w t h a t
the MMRF i s work ing
urgently to make sure
new treatments are there
for me when I relapse.”
– Carol Goldschein,
8-Year Multiple
Myeloma Survivor
Multiple Myeloma Proteomics Initiative
The MMRF in 2008 launched the Multiple Myeloma ProteomicsInitiative with the award of a collaborative grant to the University ofArkansas for Medical Sciences, Indiana University, and the Universityof Michigan. This novel program brings together world-renownedproteomics experts with experts in the clinical and biological aspectsof multiple myeloma to identify new biomarkers for the disease.
Multiple Myeloma Cancer Stem Cell Initiative
In 2008, the MMRF and the Leukemia & Lymphoma Societypartnered to award grants to William Matsui, MD, Johns HopkinsUniversity, and Irving Weissman, MD, Stanford University, to studythe multiple myeloma cancer stem cell. These grants, developed inresponse to proceedings from the 2008 MMRF Myeloma CancerStem Cell Research Roundtable, will advance our understandingof drug resistance and relapse in patients with multiple myelomaand potentially lead to the development of targeted therapies thateffectively treat the disease.
MMRF Fellows Awards
Supports researchers with less than five years experience andworking under the supervision of a research sponsor.
MMRF Annual Report 2008 7
Abdel Kareem Azab, PhDDana-Farber Cancer Institute
Tsui-Fen Chou, PhDCalifornia Institute of Technology
Alex Klimowicz, PhDUniversity of Calgary
Eva Martinez, PhDNorthwestern University
Rao Prabhala, PhDBoston VA Research Institute
Wei Xiong, PhDUniversity of Utah
Eyal Zcharia, PhDHadassah Medical Organization
“The MMRF Biotech Investment Award bridges a critical funding gap
that will support the clinical development in myeloma of our promising
novel compound, AT7519, a proprietary CDK inhibitor.”
– Harren Jhoti, PhD, CEO, Astex Therapeutics
8
Accelerating the Delivery of New TreatmentsValidationSpeeding the Next Generation of Treatments
The MMRF supports research aimed at the identification and prioritization of compounds andcombination approaches with the most potential in treating myeloma.
Validation of Novel Combinations and Novel Compounds Awards
Dharminder Chauhan, MDDana-Farber Cancer Institute
Simon Joel, PhDBarts and the LondonSchool of Medicine
Donald Kufe, MDDana-Farber Cancer Institute
Terry Landowski, PhDUniversity of Arizona
Hsiou-Chi Liou, PhDWeill Cornell MedicalCollege
Noopur Raje, MDMassachusetts GeneralHospital
Wim Vanden Berghe, PhDUniversity of Ghent
MMRF Senior Research Awards
Innovative grants supporting researchers with more than f ive years experience inblood cancer research.
David Avigan, MDBeth Israel DeaconessMedical Center
Ralf Bargou, MDUniversity of Wurzburg
Ruben Carrasco, MDDana-Farber CancerInstitute, Boston, MA
Marta Chesi, PhDMayo Clinic
Alfred Goldberg, PhDHarvard Medical School
Lori Hazlehurst, PhDH. Lee Moffitt CancerCenter
Constantine Mitsiades,MD, PhDDana-Farber Cancer Center
Shigeki Miyamoto, PhDUniversity of Wisconsin
Jetze Tepe, PhDMichigan State University
Qing Yi, MD, PhDM.D. Anderson CancerCenter
Fenghuang Zhan, MD, PhDUniversity of Arkansas forMedical Sciences
MMRF Annual Report 2008 9
Clinical TrialsFast-Tracking Clinical Trials
Committed to bringing patients the next generation of treatments asquickly as possible, the MMRF supports start-up activities and conductof Phase I and Phase II clinical trials compounds and combinationsagainst high-priority myeloma targets.
Biotech Investment Awards
With funding for pre-clinical research and early-stage clinical trialsextremely limited, the MMRF Biotech Investment Awards bridge acritical funding gap so that better, more effective treatments canbe developed more rapidly. The 2008 MMRF Biotech InvestmentAwards were granted to Aileron Therapeutics to support thedevelopment of its Stapled Peptide, and to Astex Therapeutics tosupport the development of its proprietary cyclin-dependentkinase (CDK) inhibitor.
Multiple Myeloma Research Consortium
The Multiple Myeloma Research Consortium (MMRC), incollaboration with its partners in the pharmaceutical and biotechindustries, advanced seven clinical trials of novel compounds andcombination approaches in 2008. Data show that recent clinicaltrials conducted through the MMRC clinical trials network wereopened 30 to 40 percent faster than today’s industry andacademic standard—a significant increase enabling patients toaccess new treatments three months earlier. We attribute theseefficiencies to our strong scientific leadership, standardizedcontracts and processes, and on-site project management.
2008
Phase II Merck Zolinza-Velcade
Phase II Torisel-Velcade
Phase I Elotuzumab-Revlimid-Dex
Phase I Celgene Pomalidomide
Phase I PDL Elotuzumab-Velcade-Dex
Phase I RVDD (upfront)
Phase Ib LBH589-Revlimid-Dex
2007
Phase Ib LBH589-Velcade
Phase I Semafore SF1126
Phase II Proteolix Carfilzomib(relapsed)
Phase II Proteolix Carfilzomib (relapsed/refractory)
Phase I Wyeth Torisel-Velcade
Phase I Ortho Tipifarnib-Velcade
Phase II Novartis LBH589
2005-2006
Phase I NPI-0052
Phase I Keryx Perifosine-Revlimid-Dex
Phase I Novartis TKI258
MMRC CLINICAL TRIALS
“The MMRC streamlines every part of
the clinical trials process so trials can be
up and running much faster and, as a
result, shortens the timeline in which
trials are completed and new treatments
are developed.” – Shaji Kumar, MD, Mayo Clinic
Front row, L to R: Dr. Joan Levy; Dr. Louise Perkins; Dr. Anne Farrell, FDA, Office of Oncology Drug Products;Dr. Ken Anderson, Dana-Farber Cancer Institute; Sandra Wear. Back row, L to R: Dr. Paul Richardson,Dana-Farber Cancer Institute; Anne Quinn Young; Dr. Susan Kelley; Dr. Rick Pazdur, FDA-Office of OncologyDrug Products.
Multiple Myeloma Research Foundation (MMRF) Research Roundtables bring together anextraordinary assembly of researchers, scientists from the biotech and pharmaceutical industries,technology pioneers, and representatives from the U.S. Food and Drug Administration (FDA). Thesedynamic events promote a collaborative approach to advancing multiple myeloma research to ensurethat better, more effective treatments are brought to patients as quickly as possible. In 2008, theMMRF convened three Research Roundtables.
Cancer Stem Cell Research Strategies Applications to Multiple Myeloma
This innovative Research Roundtable brought together cancer stem cell experts with leadingmyeloma researchers to gain a better understanding of the multiple myeloma cancer stemcell. Key learnings from this Roundtable were used to develop the Multiple Myeloma Cancer StemCell Initiative.
Accelerating Drug Development in Multiple Myeloma — A Workshop on Optimizing Development & Registration Strategies and Opportunities & Challenges in the Myeloma Drug Development Process
This exciting, two-day Roundtable brought together representatives from more than 20 biotechcompanies with the FDA to discuss regulatory opportunities to advance compounds in their pipelinethat show potential in treating multiple myeloma. Citing the MMRF and MMRC’s success in workingwith biotech companies, participants developed strategies to facilitate clinical trial development andenrollment and to accelerate IRB approvals. The second day of the event was a smaller meetingwhere participants discussed business solutions the MMRF and MMRC could implement to removebarriers slowing drug development and accelerate the delivery of new treatments to patients.
Championing Collaborations to Advance New Treatments
10
MMRF Annual Report 2008 11
As a patient-focused organization, the Multiple Myeloma Research Foundation (MMRF) knowsfirsthand how important it is that multiple myeloma patients and the providers who care forthem understand multiple myeloma and its treatment options. That is why the multiple myelomacommunity consistently looks to us as the nation’s premier and most trusted source of up-to-dateinformation. All MMRF educational services are available free of charge.
Cutting-Edge Web-Site
In 2008, more than 800,000 daily unique visitors viewed the MMRF’s website, www.themmrf.org.This dynamic site provides visitors with information on everything they need to know aboutmyeloma—from research updates to help finding a clinical trial. The website also hosts webcastsfrom major medical meetings, as well footage from teleconferences with research experts.
MMRF Patient Navigator Program
The MMRF Patient Navigator Program is a highly-personalized service that enables patients to findclinical trials that best match their needs. This important resource can be accessed through theMMRF’s website or by calling a toll-free number: 1-866-603-MMCT.
Educational Symposia and Workshops
In 2008, the MMRF was selected, following a highly competitive process, to sponsor educationalsymposia at several national and international workshops and meetings, including the OncologyNursing Society Annual Congress, the American Society of Hematology’s Annual Meeting andExposition, and the American Society of Clinical Oncology Annual Meeting, where it was the onlyfoundation invited to sponsor.
Newsletters
In 2008, each week, more than 16,000 people received MMRF SmartBrief, a weekly email newsletterhighlighting the latest scientific research and clinical trials, and nearly 65,000 people received eachissue of Myeloma Focus, a print newsletter.
African-American Outreach
In 2008, the MMRF launched an African-American Outreach campaign pilot in Chicago. The campaignbrought the faith-based community and civic leaders together to create a plan to raise awarenessabout multiple myeloma within the African-American community. The MMRF distributed educationalmaterials about multiple myeloma and its effects on the African-American community through thechurch health ministries and community health centers. In the year to come, the MMRF will buildupon this campaign in other major urban cities throughout the country.
Educating the MultipleMyeloma Community
The MMRF hosted numerous successful events in 2008, raising millions of dollars toadvance the MMRF’s innovative research portfolio.
MMRF Chicago Awards DinnerApril 23, 2008Chicago, Ill.
The 7 th annua l Ch i c ago
Awards dinner raised more
than $750,000 and drew more
than 500 guests. Legendary
actress and cancer survivor
Diahann Carro l l prov ided
the keynote address , and
actor and comedienne Bonnie
Hunt served as Mistress of
Ceremonies for the sixth time.
Olympic gold medalist and
two-time cancer survivor Scott
Hamilton, the 2007 recipient
of the Spirit of Hope award,
was also an honored guest.
Vice Chairs & Corporate Chair, with the evening's special guests, from L toR: Brian Feltzin, Robert DeBaun, Lester Knight, Diahann Carroll, Connie L.Lindsey, Bonnie Hunt, and Joe Damico
Jim Moriarty (far R) and friends
Raising Fundsfor Research
12
Deborah Norville, Karen Andrews, Cindy Crawford, Tiki Barber,and Kathy Giusti
MMRF Fall GalaNovember 1, 2008Greenwich, Conn.
More than 900 guests attended the 12th annual MMRF Fall Gala, which
raised more than $1.5 million for myeloma research. The Spirit of Hope
Award was presented to supermodel, actress and spokesperson Cindy
Crawford and former New York Giants player Tiki Barber, now an NBC news
correspondent and analyst for NBC’s “Football Night in America”. Deborah
Norville, host of “Inside Edition” and author of Thank You Power, returned
as Mistress of Ceremonies. Other honored guests included former
Congresswoman and myeloma patient Geraldine Ferraro, Congressman
Christopher Shays, sportscaster Bob Costas, and Melanie Bloom, widow of
NBC news correspondent David Bloom.
MMRF Annual Report 2008 13
Traver and Elizabeth Hutchins
Geraldine Ferraro and Deborah Dunsire
Rebecca Lobo, Chris Russo, Alan Kalter, and Congressman Shays
MMRF Race for Research andMarathon ProgramMMRF 5K Race for Research events raised nearly $1.8 million in 2008.
Races were held in nine cities, with thousands of participants, many of
them myeloma patients and their families, leading the way in the
MMRF’s race toward a cure.
2008 was also the inaugural year of the MMRF Marathon/Half Marathon
program. Sixty-two runners raised nearly $300,000 in races in 10 cities,
most notably the prestigious Boston Marathon, ING New York City
Marathon, and Chicago Marathon.
MMRF Race for Research —Philladelphia youngstersenjoying the beautiful day
Running for My Dad,
Raising Funds for Research
“ B e i n g p a r t o f t h e
t e a m t h a t t r a i n e d
a n d r a i s e d f u n d s
fo r the MMRF was a
priceless experience.”
– Jodi Manby (on rightabove), who ran the Santa Barbara Wine
Country Half Marathon in honor of her father,
a myeloma patient
Raising Fundsfor Research
14
George and Norma Fabian
Kathy Giusti, and Ellie and Barry Samson
MMRF Laugh for LifeMay 20, 2008New York, N.Y.
The 6th annual Laugh for Life event, created by sisters Carol Goldschein, Sue Korn
and Cindi Stern raised more than $550,000 for myeloma research. The sold-out event
was hosted once again by comedian Paul Mercurio and featured comedians Pete
Dominich, Ted Alexandro, Andrew Kennedy, and Dan Naturman. Carol Goldschein,
whose myeloma diagnosis originally inspired Laugh for Life, was honored with
the Spirit of Hope Award. Alan Kalter, announcer for the “Late Show with David
Letterman”, was an honored guests, and Marcia Zisselman and family were
presented with a special award for their outstanding contributions to the event.
MMRF Investors CircleScientific SummitOct. 14-15, 2008Greenwich, Conn.
The 4th annual MMRF Investors Circle Scientific Summit,“Accelerat ing Drug Development: Progress Toward aCure,” brought together academia, industry and high-impactphilanthropic donors in a discussion of current research to helpdonors better understand the research initiatives they aresupporting. Speakers included leading researchers from theDana-Farber Cancer Institute, the Moffitt Cancer Center & ResearchInstitute, Proteolix, Inc., and Keryx Biopharmaceuticals, Inc.
MMRF Annual Report 2008 15
Spirit of Hope Award honoreeCarol Goldschein
CommunicatingOur ModelIn 2008, the Multiple Myeloma Research Foundation (MMRF) received extensive print and broadcastmedia coverage of its important work in breaking down barriers to research and drug development.Major media outlets featured the MMRF’s groundbreaking approach to funding myeloma researchand bringing new treatments to patients.
In its Jan. 28 issue, The New Yorker profiled MMRF Founder andCEO Kathy Giusti in an in-depth article entitled “Buying a cure:What business know-how can do for disease,” which traced the development of the MMRF andhighlighted Kathy’s determination and achievements in promoting collaboration in myelomaresearch and the development of new therapies.
Forbes magazine featured the MMRF in its Sept. 15 issue in thearticle “Patient Power,” which underscored the Foundation’ssuccess in promoting and funding research, achieving a leadership role in the biotech andpharmaceutical industries, and speeding up the drug development and approval process.
The MMRF was also featured in the Sept. 4 issue of Time magazine,which highlighted the Foundation’s model for developing more effectivetreatments in the article “He Won His Battle with Cancer.”
MMRF Founder and CEO Kathy Giusti was one of eight Harvard Business Schoolgraduates profiled in a CNBC special report, “The Money Chase—Inside HarvardBusiness School,” which focused on how Kathy has used her business trainingand acumen to create an innovative research and drug development model.
MMRF Executive Director and Chief Operating Officer Scott Santarella rang the bell to opentrading on the NASDAQ stock exchange on Thursday, December 18, 2008. MMRF staff andfriends attended the bell ringing ceremony, which took place at NASDAQ’s MarketSite andBroadcast Studio in Times Square and was broadcast on channels nationwide.
16
MMRF ExecutiveDirector andCOO ScottSantarella andMMRF staff and supportersat the NASDAQbell ringing ceremony
Maximizing Our ResultsIn 2008, the MMRF was invited to share best practices at several internationalthink tanks and summits, including the Biotechnology Industry Organization (BIO)International Convention, Health Research Alliance (HRA) National Conference, andthe TransMed Partnership Forum.
MMRF Founder and CEO Kathy Giusti was also a keynote speaker at the DrugInformation Association (DIA) Annual Meeting and the American Association of CancerResearch (AACR) Industry 2008 Roundtable, where she delivered a keynote address inpartnership with Lori Kunkel, MD, Chief Medical Officer at Proteolix.
MMRF Annual Report 2008 17
Kathy Giusti with Lori Kunkel, MD, and MargaretFoti, PhD, MD, AACR
18
Financials
The MMRF 2008 Audit reported that the Foundation raised$22.7 million.
*Based on gross revenue
MMRF Annual Report 2008 19
Support and Revenue 2008 2007
Contributions $ 7,001,152 $ 4,319,668Private foundation grants 9,936,269 9,883,022Federal grant support 475,796 465,846In-kind contribution 24,404 13,695
Special eventsSpecial events support 5,264,974 7,874,323Less special events expenses (1,780,555) (1,808,862)
Investment return 32,692 239,915
Total support and revenue 20,954,732 20,987,607
ExpensesProgram
Research 13,815,646 14,156,123Education 1,666,752 2,286,439Awareness 364,599 489,049Other program expenses 1,206,472 1,074,625
Total program expenses 17,053,469 18,006,236
Supporting servicesManagement and general 552,453 526,719Fundraising 1,781,766 839,041
Total supporting services 2,334,219 1,365,760
Total expenses 19,387,688 19,371,996
Change in net assets 1,567,044 1,615,611
Net assets, beginning of year 4,778,467 3,162,856
Net assets, end of year $6,345,511 $4,778,467
Multiple Myeloma Research Foundation, Inc.Statements of Activities (Audited) – Years Ended December 31, 2008 and December 31, 2007
MMRF Board of DirectorsW. Dana LaForge, Chairman
Kenneth C. Anderson, MD
Karen Andrews
Robert J. Beall, PhD
Robert B. DeBaun
Frank Douglas, PhD, MD
Kathy Giusti
Stephen Grand
Eugene Grisanti
Alan L. Heller
Frederick H. Joseph
Anthony K. Kesman
Thomas J. Kipps, MD
Lori Marcus
Gerald McDougall
William S. McKiernan
Mike Mortimer
Charles B. Ortner
Edward Jay Phillips
Stuart Rosow
William Wilson, III
Donna Zaccaro
MMRF Honorary BoardLance Armstrong
Dusty Baker
Tiki Barber
Don Baylor
Diahann Carroll
Bob Costas
Katie Couric
Cindy Crawford
Ann Curry
Geraldine Ferraro
Scott Hamilton
Mariska Hargitay
Bonnie Hunt
Senator Kay Bailey Hutchison
Dan Jansen
Diana Krall
Eric McCormack
Deborah Norville
Keith Olbermann
Sharon Osbourne
General Norman Schwarzkopf
Mel Stottlemyre
Brian Williams
Robert & Lee Woodruff
Paula Zahn
MMRF Leadership Council
Joseph M. Hogan
Lester B. Knight
Philip J. Purcell
Robert Wolf
Leadership
20
Donors
Celgene Corporation
Linda Rodgers Emory
Stephen & Nancy Grand
Marvin Family
Millennium Pharmaceuticals, Inc.
Avinoam & Eti Naor
Edward & Leslye Phillips
Pioneer Fund
Sam & Peggy Johnson
Susan Marvin
Schuett Family Foundation
Amgen
Anonymous
Richard & Vicki Birdoff
BSL Capital Inc.
Centocor Ortho Biotech
Robert & Jane DeBaun
Elizabeth H. Donald
Genentech, Inc.
Mike Windsor — Interpacific
Holdings Inc.
Laszlo N. Tauber Family
Foundation
Frank & Margaret Marvin
Novartis
Leon H. & Cindy Rittenberg, Jr.
Barry & Ellie Samson
Thomas & Gertrude Tibstra
Foundation
Valerie Ann Luff Foundation
Estate of Francis I. Wilks
A. Morris & Ruth W. Williams, Jr.
William & Pat Wilson, III
Ambrose Monell Foundation
Vincent & Jennifer Browning
Timothy Curt
Donaghue Foundation
Eli Lilly & Company, Inc.
George & Norma A. Fabian
Steven & Carol Goldschein
Estate of Linda L. Gunther
Steve & Nancy Kaufman
Keno Graphic Services, Inc.
Kyphon, Inc.
Max Fund, Inc.
John E. & Sarah McGinty
Avis J. Mello
Merck & Co., Inc.
David & Anne Ogilvy
Rocco & Patricia Palmer
Pfizer, Inc.
Proteolix, Inc.
Kenneth & Cynthia
Anderson, MD
Aon Foundation
Atlantic Philanthropies, Inc.
Warren L. & Paula Berliner
Chris Blackwell
Blue Oak Charitable Fund
Marc A. Cohen
Richard Corman
Joe & Pam Damico
Daryl & Jamey Daugherty
Bob & Jane DeBaun
Mark B. Dreyfus
Exelon Corporation
Brian & Allison Feltzin
Mark & Laura Fishman
Paul & Kathy Giusti
Eugene & Gretchen Grisanti
Grosvenor Capital
Management, LP
Ted & Paula Sue Heppner
William Hodges & Paula
Mercer, Jr.
Joseph & Lisa Hogan
Robert Hugin
Ed Johnson
Louise Kepley
Anthony K. & Barbara Kesman
Lester & Becky Knight
Kosan Biosciences, Inc.
Dana & Kathleen LaForge
Bob & Lynn Lunn
James Marcus & Lori Tauber
John Marvin
Lois M. McKeag
McNamara Purcell Foundation
The Mihelcic Family
Northern Trust Corporation
Charles Ortner
Rockville Centre St. Patrick’s
Parade, Inc.
SAC Capital Advisors
Tom Snitzer
Nick & Becky Tiller
Towerbrook Capital Partners, LP
TracyLocke
John Twyman
UBS AG
Paul Ullman & Donna Zaccaro
Dorothy R. Underwood
Robert & Carol Wolf
Valentina V. Wuorinen
Newton & Pam Yaeger
Don E. Ackerman
Adco Electrical Corp
Robin Albert
Woodbury H. & Cynthia A.
Andrews
Anonymous
Dean & Kimberly Assink
Baxter International, Inc.
Bayer HealthCare
Pharmaceuticals
Harvey & Joyce Birdoff
David W. & Alison L. Blood
William Butler
Carlson Family Foundation
Richard A. Carter
Joseph Cassano & Ellen Hooker
Cephalon Oncology
Michael Chiusano
Circle of Service Foundation, Inc.
Thomas Conheeney
Cooper Family Foundation
Robert Costas & Jill Sutton
William E. Covey Memorial
Golf Tournament
Crowell Family Foundation, Inc.
James & Susan Davie
DDB Worldwide
Communications Group, Inc.
Donation Line, LLC
William & Cathleen Ellsworth
Dennis Erdle & Lori Pugh-Erdle
Evert Family Charitable Fund
William & Sharon S. Feather
$10,000 TO $24,999
$25,000 TO $49,999
$50,000 TO $99,999
$100,000 TO $499,000
$500,000 TO $999,000
$1 Million+
The support of our donors has ensured that the progress we have made in multiple myeloma will notlose its momentum. The Multiple Myeloma Research Foundation (MMRF) would like to extend itsheartfelt gratitude to all those who contributed to the MMRF in 2008. The following pages gratefullyacknowledge those generous donors from January 1, 2008 through December 31, 2008*.
MMRF Annual Report 2008 21
DonorsKenneth B. & Ellen Forrest
Fran Friedman
Jay & Victoria Furman
GE Capital
Nanny Gifford — Drueding
Foundation
Morris & Gertrude Furman
Foundation
Glancy Foundation, Inc.
Global Impact
Go Green Self Storage
Goldener Executive Search
Associates
Stanley & Pearl Goodman
Arnold & Roberta Greenberg
Hackberry Endowment Partners
Alan & Abbe Heller
Grant Hutchins
Traver & Elizabeth Hutchins
Web Hutchins
Evelyn Illich
Lorraine J. Illich
Interactive Brokers
Group/Timber Hill, LLC
Henry Jarecki
Fred Joseph & Linn Anderson
Kastory Family Foundation
Katzen International, Inc.
Kirkland & Ellis, LLP
Knight Capital Group, LLC
Valerie Krause
Landmark Companies, LLC
Dale Lang
Steven & Wendy Langman
Christopher M. & Katherine A.
Linneman
Carl & Katherine Locher
Martin & Tristen Mannion
Marion Moore Foundation
Neville & Kitty Martin
McCarty Cancer Foundation
McCormick Tribune Foundation
Jack & Julie McGinley
McGinn, Smith & Co., Inc.
William S. & Betsy McKiernan
MediZine
Paul & Jill Meister
W. Lane Miller
Moneta Group, LLC
Eddie & Irma Muller
William B. O’Connor, Esq.
Paul & Anne-Marie Queally
Family Foundation
PepsiCo
Jeanne Phillips
PricewaterhouseCoopers
Reyes Holding, LLC
Allen & Vicki Samson
Jordan Saper & Ms. Jill
Rittmaster
Leonard A. Sarnat
Say Yes To Education
Foundation
Perry Snyderman
Matthew & Marnie Spiegel
Tribal DDB Worldwide
Ungaretti & Harris
Howard & Mindy S. Unger
Vander Werf Family Foundation
Jerry & Susan Walton
Wapping Community Church
Peter & Deborah Weinberg
Jeffery K. & Mary Wirth
World Wrestling Entertainment
The Yazbak Family
Izzy Zalcberg
Craig & Heidi Albert
Karen Andrews
Anonymous
Etta Atkin
Nina Atkinson
Atiim & Virginia Barber
Alvery A. Bartlett, Jr.
Baxter Credit Union
Baxter Healthcare Corporation
Elisabeth R. Bennett
Melanie Bloom & Dan McNulty
Steve & Joyce Bloom
Michael & Susan M. Blum
Richard Boas
John & Margaret Brewer
Brook and Whittle, Inc.
Michael Brooks
Brookstone Homes, Inc.
Mark Brown
Brown Rudick Berlack Israels, LLP
Wally Buchband
David & Carey Burwick
Robert B. & Andrea Callagy
Canyon Ranch
Cardinal Health
Charlotte & William Hindon
Charity Foundation
Mark J. & Katherine Chelsky
Christopher & Julie Ellen Church
John & Lisa Clark
Constantine L. Clemente
Conventures
Cordis Corporation
Daniel & Lori Crowley
CSX Corporation, Inc. Financial
Services
Cuisinart Resort
De Santis
R. Thomas & Denise Decker
David J. Deutsch
Donahue Foundation
Thomas & Marilyn P. Donnelly
Richard Dvorin
EMD Serono Research
Institute, Inc.
EOS Foundation
Epstein Becker & Green, PC
Estate of E. Charles Uphoff
Rand & Lynne Eyberg
Fenwal, Inc.
Richard & Lori Fernandes
Geraldine Ferraro & John
Zaccaro
Joseph & Frances Ferrone
Doug Fierro
Michael Fisch
Kevin M. & Janice Forde
Four Seasons Resort Costa Rica
at Peninsula Papaga
Mark & Cynthia G. Fuller, III
John M. & Grace Gallaway
GE Commercial Finance
Geotechnical and Environmental
Cons., Inc.
Eugene Gluck
Jeff Goldberg
Malcom & Louise Goodridge
Greyhawk Capital, Inc.
Gutman Family Foundation Trust
Hachette Book Group USA
Cici Halloway
Steven Handwerger & Vera
Thomas
Joshua Harlan
Harrah’s St. Louis Casino
& Hotel
David Helfand
Gerald Hirsch
Hollister, Inc.
George & Diana Holway
Horizon Construction Company
Aura Hulme
Illinois Tool Works, Inc.
Infinity Discovery, Inc.
Intermountain Eye & Laser
Centers, PLLC
James McNaughton Builders, Inc.
Edgar D. & Deborah Jannotta
Johnson & Johnson Family of
Companies
Louise Jones-Takata
John M. Joyce
Keryx Biopharmaceuticals, Inc.
Jinwoo Kim
Kirkland & Ellis Foundation
Knott Family Foundation
Jonathan & Sue Korn
Langan Engineering and
Environmental Services
Jack Laschever
Ed & Rose Leventhal
Connie L. Lindsey & John M.
Blackburn
Marjorie Loeb
Loop Capital Markets
Sam & Gabrielle Lurie
Linda Lynn
Kevin & Sheri Lyons
Marquette Partners
Marsh Family Foundation
Martin Partners, LLC
Marx-Better Foundation, Inc.
Gerald & Jennifer McDougall
Miles for Myeloma
Modell Sporting Goods
Morman Group, LLC
MPI NorthEastern NY Chapter
National Basketball Association
$5,000 TO $9,999
22
Everette Newman
Newsweb Corporation
Deborah Norville & Karl Wellner
NRG Energy, Inc.
Loretta Peavey
Marc Pelath
Per and Astrid Heidenreich
Family Foundation
Gloria Perry
PJ Callahan Foundation, Inc.
Private Bank and Trust Company
Chris Reading
Marc & Rosemary Reisch
Jose & Elizabeth B. Ribeiro
Richard Davoud Donchian
Foundation
Lisa & Jay Ring
Ritchey Family Community
Property
Robert Wood Johnson
Foundation
Adam T. & Amy F. Rochlin
Jim Rushin
Gary Sampere
David & Cindi Samson
Sawdust Investment
Managment, Inc.
Edward & Barbara B Scolnick
Pamela R. Shiells
Rocco & Venus Simonetta
Skadden, Arps, Slate, Meagher
& Flom, LLP
Barbara & Ozzie Smith, Jr.
Jonathon & Laurie Soler
St. Vincent’s Comprehensive
Cancer Center
Steck’s Nursery
John & Charlotte Suhler
Teitelbaum Family Charitable
Remainder Unitrust
Tennenbaum Helpern Syracuse
Hirschfritt
Steven Todd
Nancy Van Leuwen
John L. & Barbara Vogelstein
VS Media, Inc.
Elizabeth Warnock
Warren Area Board of
Realtors, Inc.
Washington University Medical
School
William & Barbara Welke
Frederic White
Wintrust Financial Corporation
Pierre & Debbie Wolf
Charles & Carol Young
Marcia Zisselman
ABC News
Arvind Agarwal
Alsan, Inc.
Alston & Bird, LLP
America II Electronics Corp.
Analog Devices
Peter Anderson & Virginia E.
Marvin
Douglas M. Balog
Basser-Kaufman
Leonard S. & Elizabeth Baum
Sandye Berger
Judith Bernhaut
John & Anne Boehle
Jim & Carolyn Bouchard
Bradford Renaissance Portraits
Mary J. Brenneis
George & Zula Crichton-
Brigham
John J. & Barbara M. Burns, Jr.
Thomas W. & Mary Jean
Buschman
Paul Butler
Timothy Carmack
Cars4Charities
Clayton T. Carter
Paul & Cristine Carter
Douglas E. Cauthen
Chesterman Beach Tofino
Andrew & Elizabeth Crossfield
Dacon Corporation
Denihan Hospitality Group
Design Lighting By Marks
Betty Dickson
Daniel & Nancy Donoghue
Edward & Sandra Meyer
Foundation
Enterprise Rent-A-Car
Foundation
Rae Etherington
Jonathan Fleisig
FlightStar, Inc.
Four Seasons Beverly Hills
Frankford Hospital
Fuscone Family Foundation
George Ganem
Philippe Gauthier
George Backer Family
Foundation, Inc.
Geron Corporation
Robert Gifford
Emerson & Carol Gilbert
Give With Liberty Employee
Donations
GivingExpress Program from
American Express
Arnold L. & Merle Goodman
Graycor Services, LLC
Gwendolyn Halsey-Albertson
Foundation
Dale Haase
David & Audrey M. Hammer
Martin & Callistheni S. Hayes
Kaye Hayley
Lloyd & Cathy Heller
Helmar Foundation
Herschend Family
Entertainment Corp.
Hospira Foundation
Robert & Michelle Hougie
Hughes Network Systems
Human Genome Sciences, Inc.
I Do Foundation
IMS Shared Business Services
Interdecor
Jack and Bessie Fiterman
Foundation
Linda Jacob
Dr. Sundar Jagannath
Jay and Rose Phillips Family
Foundation
Lawrence & Bette M. Kahn
Robert (Kam) & Judith
Kamerschen
Kasey Kahne Foundation
Paul Katz
Stanley & Carol Kay
Robert & Dawn L. Kern
Gloria R. Kindman
Marc Klahr
Ian & Carol Knight
E.A. Kratzman & E.A Kratzman
John & Kennetha L. Krehbiel
Laurens Leffingwell
Kenneth & Lilian Lockman
Mike Lynch
M Milestones of CT, LLC
Dariush Maanavi
Kim Marrkand
Stephen Marshall & Sandy
Samberg
William A. & Bobbie Marvin
Paul & Carol McDermott
McGregor Fund
Gerald L. & Donna M.
McMahon
Vince & Linda McMahon
Stacy Mendler
Merrill Lynch & Co. Foundation
Inc. Matching Gifts
Melissa Ann Meschery
William Miely
Tom Mihelcic
H. Kurt Von Moltke
Morgan Stanley
Jay A. Motula
Bruce & Hilary Murray
Stephen & Kimberly S.
Niggeman
Northern New Jersey Cancer
Associates
Michael O’Halleran
Ted Orenstein
Alan Panzer
PDL BioPharma, Inc.
Laura A. Pepper-Doyle
Lousie Perkins, PhD & Jeff
Glans, PhD
Roland & Adelene Perkins
Plaza Construction Corporation
Charles Polizzi
Alan & Sharon Wolmer Portnoi
Milton & Elinore Povill
Progressive Rail
Charles & Ora Ramat
Resource Management Group
Gene & Tracy Rigo
$2,500 TO $4,999
MMRF Annual Report 2008 23
DonorsMilton & Judith Riseman
River Cats Foundation, Inc.
Roberts & Holland, LLP
David & Debra Robson
Alfred & Eileen Rossi
Victor & Deborah M. Sauerhoff
John Schmuck
Lewis & Barbara Schneider
Schwab Charitable Fund
Scripps
Ted & Jennifer Serentelos
Bob & Andrea Sheehy
Bippy Siegal
Marc Silberberg & Barbara
Julius
SOAR Foundation
Raymond & Julie Soffientini
Solon E. Summerfield
Foundation, Inc.
Susan Spagna Dorfman
Pellegrino & Kathy DeLeo-
Spagnuolo
Sparks Exhibits &
Environments Corp.
Bette F. Stein
Steven Steinman
Jay & Katie Stevens
Stanley & Madonna Manley
Swete
Pamela Tate
The Frederick & Margaret
Weyerhaeuser Foundation
The Mahley Family Foundation
Laura Toby
Tulane University
Ronald Unger
University of Pittsburgh
Sanford & Bernice Waldman
Warner Bros. Records
Douglas Waters & Virginia
Johnston
Steve & Becky Watson
Charles & Phillipa Wendel
Donald & Cynthia Wieneke
Stan Wilemon
Michael Winkler
Paul Witteman & Ellie McGrath
Ira & Shirley Yohalem
Zenner Consulting Group, LLC
Todd Zimmerman
Jeff Zisselman
Arnold & Michele Zousmer
3750 Monroe Avenue Associates
Patricia E. Gaither Adams
Ades Foundation
Dave Aho
Jack S. & Margaret Aiello
Marvin & Heather Albert
Elaine Alexander
Alexandria Animal Hospital
Roberto & Melissa Alvarez
Rebecca Aminoff
Susan Amsterdam
Vidya Sagar Anisingaraju
Anreder & Company, Inc.
Barbara Aranowitz
Josephine Arduni
Arizona Verde Fire Protection
Ark Restaurants Corporate
William & Sarah Armstrong
John & Bonnie Arrix
AST Capital Trust Company
of Delaware
Daniel Auclair
Constance Bagley
David Bainbridge
Miriam Bareket
John Barry
Virginia Bartch
Janet W. Battaile
Bead’t for Mulitple Myeloma
Robert J. Beall, PhD
Jed & Elizabeth B. Becker
Ben Larrabee Photography, LLC
Benchmark Technologies
International Corp.
Benesch, Friedlander, Coplan
& Aronoff, LLP
James Berbee
Reid Berman
Robert L. & Libby Berner
Carla Berryann
Hugh Beryman
Victor & Karen E. Binsacca
BJC Healthcare Corp.
Brian & Heiji Black
Charmaine H. Blatt
Doris Blau
Brandon & Janet Blaylock
Henry Block
Charles Boardman
Arnold Bodmer
Michael & Vickie Bolger
Michael Bolling
BOSE Foundation, Inc.
Kenneth A. & Marianne
Bouldin
Gwen Boyd
Michael Boyd
Alan S. & Elizabeth Breece
Breslow Foundation
Brighton Foundation Trust
Rusi & Renu Brij
Bernie Brillstein
Ernie & Ruthie Brod
Duffy W. Brodsky
Brooks Charitable Fund
Brown and Brown Metro
Buddy Brown
Curtis Brown
Bruno’s Semi Trailers
Suzanne Lunt Bubrosky
Joseph D. & Sarah M. Burke
Ned Burns
John & Colleen Busch
Donald & Sara Bush
Greg & Lora Butler
Robert & Lynn R. Callagy
Leonora A. Callahan
J. Terrence & Sharon E.
Carleton
Gregory A. Carlin
Sandra Carlisle
John K. Castle
CDW Corporation
Centre Partners Management,
LLC
Monica Chandochin
Charles and Ann Johnson
Foundation
Charles Engelhard Foundation
Charles River Laboratories, Inc.
Charter Management Company
Arnold & Nilene Evans Chase
Frank Cheatham
Faris & Christine N. Chesley
Gregory & Robin Chess
Paul Chiusano
David Chizewer
CIBC World Markets Corp.
Ciber
Citi Global Impact Funding
Trust, Inc.
Citigroup Global Impact
Funding Trust
Thomas R. Clark
Mark Claude
James & Virginia D. Cleaver
Robert & Donna Clemmens
CME Chicago Mercantile
Exchange
Coakley Tech
Raymond & Karen G. Cohen
Douglas & Suzanne T. Cole
Richard & Kathy Collins
John Comerford & Teresa Olle
Gregory & Robin Comfort
H.R. & Jean T. Compton
Continuum Health, LLC
Harvey Coopersmith
Richard W. Courts
T. Brad Courts
Coventry Health Care, Inc.
Andrew Jay Cowen
Lee & Marilyn Cox
Stuart Crames
Crist Associates
Donald & Toni Crowley
Douglas Cummins
Joseph & Marcie Cunius
Ken C. & Helen Curtis
William R. Cutter
D’Agostino Landscaping, Inc.
Robert & Sara Dalelio
Richard Darling
Frank Z. Davidson & Carol
Fishberg
Michael & Cara Davidson
Davidson Management
Holding, LLC
Davis Wright Tremaine, LLP
Perry De Valpine
Fred Deandrea
John Debacco
$1,000 TO $2,499
24
John & Gayle W. DeBaun
Anthony Decello
Kent DeLucenay
Robert & Ilene Gerstein
Diamond
Jon & Jeanne Director
Dobbs Tire & Auto Centers
Susan Doherty
Bill Donan
Dorothy G. Bender Foundation
Downers Grove Junior
Womans Club
Keven & Yvette Drews
Kimberly Duchossois
Richard & Bonnie Dudley
Kay DueFrene
Thomas L. Duncan
Tom Duncan
Dawn Duquaine
Timothy & Beth Dwyer
Hugh Eaton
Pete & Mia Edwards
Mark & Sandy Ehlert
Richard F. Eisenberg
Richard & Maribeth Ellsworth
David M. Elzemeyer
Thomas Embrescia
Sandor & Sue Engel
Norm M. & Mari Epstein
Oliver Esman
James P. & Kim Fahey
Ursula Fairbairn
Fairmount Park Commission
Frank Fanning
Jo Anne Fasetti
Donna Feig
Robert H. Feldman
Fiesta Bowl
John & Judith Finley
John G. Finley
Joe & Mary Finley
Finnegan Foundation
Donna L. Finney
First United Bank
Helge & Cathy Fischer
Martin & Aurea Fisher
Max & Cindy Fisher
William & Anne Flanagan
Michael Fleischer
Ninetta Fleming
Jay Flynn
Forest Oil Corporation
Elizabeth Foster
Four Seasons Jackson Hole
Jeffrey & Rosalind J. Freidus
Barry & Stacie Friedman
Alan & Ilene Frost
FSH Communications, LLC
Jesse Furman & Ariela Dubler
L. Patrick Gage
John & Susan S. Gainer
Dennis M. Galgano
Jonathan & Amy Gallen
Joseph & Kathleen Gallichio
Edward J. & Diane Gannon
Gar Advertising, Inc.
David & Barbara Garodnick
Garrett Capital Advisors, LLC
Gary & Bernice Lebbin
Foundation, Inc.
A. George & Lea Allen Gebauer
Carol Geer
Arthur & Norrine T. Geib
Gelber Foundation
Michael & Mary Gellert
Georgica Advisors, LLC
Eric Gerster and Padmini Nunna
Edmond Ghisu
G-III Apparel Group, Ltd.
Kenneth Gladden & Dawn
Lepore
Michele Glassser
Barbara Goldberg
Richard Goldberg
Adam & Alicia Grabow
Martha Graettinger
Peter & Elizabeth Granath
Elizabeth Grayer
Robert Greenberg
Michael & Betsy Greene
Gross & Gross, LLP
Stuart & Joan B. Gross
Bruce Grossman
Robert J. Grossman
Group Voyagers, Inc.
Marshall & Rebecca Grueber
David & Jennifer Baum Gruen
David & Blair Grumman
Richard & Doris Gurtler
Brad Gwinn
Claude Gwinn
Ashraf Habibullah
Bruce Hackmeyer
Philip & Susan G. Hagen, Jr.
Carl E. Hale, Jr.
Halland Companies
Connie Hallblade
Bradley Hamburger
Walter W. H & Eleanor Hamilton
John & Cathleen Hammerschlag
Margaret Happel
Jane Harewood
Harold E. Hirsch Foundation, Inc.
Harris N. A.
Robert L. & Maria Hart
Hawaii Community Foundation
Jeff Hawkins & Janet L. Strauss
W. E. Hays
Charleen C. Hebert
Hecht and Company, PC
Ronald E. Hedlund
Heather Heintzman
Gary Heinze
Heraeus Tenevo, Inc.
Hermann Living Fund
Bernard & Marion Herzberg
Hess Companies
Paul M. & Kathryn Houston
Higbee
Barry & Anne L. Hilton
Alan Hoberman
John & Bonnie Hoegl
Douglas Hoerr
Stephen Holowesko
Holzman Family
Howard & Lois Honigfeld
Daniel & Sarah Hooke
Karen Horan
Howard & Maryam Newman
Family Foundation
HR Impact, Inc.
HSBC Philanthropic Programs
A. H. Huntington, III
Judy Hurley
Husch Blackwell Sanders, LLP
Jack Huston
Doug & Sheila Hyman
Jay Iams & Patricia G. Iams
Stephen N. Ifshin, II
Laurie Imhof
Alice Impraim
Infinity Development Corp.
Shawn Ingall
IT Technology
Dale & Amy Izatt
Cecelia Jacques
Mavis James
Nancy Jarecki
Kenneth D. Jenkins
Timothy & Susan A Jensen
Jersey Development, LLC
Jewels of Ocean
JHL Capital Group, LLC
JLL Partners, Inc.
Ken Jockers
John & Joan D’Addario
Foundation Inc.
Christopher J. & Wendy M.
Johnson
Jeffrey & Danyel Johnson
Judy B. Johnson
Jon and Mindy Gray Foundation
Kevin Jordan
Martin J. Joyce
JSM Marketing, LLC
Alan & Peggy Bell Kalter
David & Marianne Kaplan
Mark Kaplan
Robert & Robin Kaplan
Kaplan Rosenow Family
Foundation
Katten Muchin Rosenman
Foundation, Inc.
Michael & Christine Kauffman
Sue Kavetas
Judy J. Keller
Robert Kemp
J. Michael Kennedy
Kenneth Cole Productions, Inc.
Ryan T. Kenny
Kent Family Charitable
Richard Kessler
King-Casey, Inc.
John & Catherine Kirchner
Jeanine Koch
Kia Swee Koh
MMRF Annual Report 2008 25
DonorsKohlberg & Company
David & Lesly R. Koo
Ken Koopersmith and Linda Rice
Richard & Claire Korn
Harry & Julie Kraemer, Jr.
Jack A. & Linda D. Kraemer
Richard W. & Ellen A. Kramer
Stanley & Shirley Kritzik
Frank & Karen Krohn
Calvin & Debbie Krosch
Len & Barb Kuhr
Sanjeev Kumar
Stuart Kuritsky
Mitchell & Galia Kurman
Joel Kurtzberg
Richard Kuzmar
Michael J. Patricia S. Laas
Dave Lager
James L. & Virginia G.
Lakemeyer
John & Mary Lane
Timothy Lane
Snyder Langston
Laura Ziskin Productions
Marta Jo Lawrence
Lawrence and Frances
Bloomberg Foundation
Bob & Jeanette Leaf
Leahy Family Foundation
Douglas & Louise Leatherdale
Philip & Susan Lebowitz
Harold & Lynn P. Leftwich
Lehman Brothers, Inc.
Daniel & Sandra A. Leib
Jules & Mimi Leibman
Pat Lennon
Leonard Jackson Associates
Dominic Lepore
Michael Lerner
Ruth R. Leventhal
Debra Levin
Jerry & Carol L. Levin
Charles & Lori B. Licht
Ted & Sara Liebowitz
William & Annette Lifford
John Lillard
Linek
Howard & Lonnie Lipson
Brian Little
John B. Lowe, Jr.
LRC Photography
April Lubiani
Gerald M. & Alison Luff, Jr.
Pamela M. Lunny
James J. & Mary F. Lynch, Jr.
Nicholas Lynch
Don MacDonald
Anthony & Evelyn Joyce Macino
Sissy Madden
Joe Madonia
Joel K. Manby
Robert & Elizabeth Mandy
Keri & Shelly Manheim
MannKind Corporation
Marangi Disposal
Marcone Appliance Parts Co.
Bo & Julie Marcus
Marina Shrady Desings
Len Mark
Mitchell & Joan H. Markow
Leonard & Marion Marsh
William Martin & Harriet
Golding
Daniel & Kristine D. Marvin
Paul & Maureen H. Marvin
Sarah Marvin
Brian Mastroberti
Worthington Mayo-Smith
Donny McArdle
Elizabeth McCarthy
Peter McCarthy
McCarty Associates
Dennis McClure
Chuck McDaniel
Michael S. McDonough
William K. McGowan
Tom & Laurie Mcgrath
Catherine Michele McHugh
Rebecca McKinney
Jeremy Mckown
Sean & Tracy McManus
Mark & Michelle McMaster
Michael & Gayle McMurry
Clarence Meadows
Thomas F Meagher, Jr.
Ann C. Means
Merrill Lynch & Co.
Foundation, Inc.
Metropolitan National Bank
Charles Metzger
MH Podell Co.
Midway Maintenance, Inc.
Steve Miely
William D. Miely
Millenium Homes
Lyle & Jerrie Miller
Greg Mills
Gregory & Lesa R. Mills
Martin J. & Mendelle Milston
Donald & Suzy Mings
Minocan Investment, Inc.
Arthur & Margaret M. Minson
Irvin M. & Maria Moldlin
Susan Molineaux
Robert Morefield
Alan Morris
Michael & Laurie Morris
Michael & Linda Morris
Don Morrison
Pamela Morrison
Morton’s Steakhouse
Tom & Joan Moverman
Mark & Lemoy Muller
Storch Munves
Steve & Mary Murdock
Erica Murray
Mary Theresa Murray
Matthew & Carla Murray
Robert & Dorothy Nakea
Izak & Susan Namer
Alfred L Nardini
David & Abigail Nash
Rebecca Nassikas
National Football League
Douglas C. & Linda A. Neilsson
New Canaan Baseball/Softball,
Inc.
New England Rugby Referee
Robert & Erin Noonan
James J. & Colleen A. O’Connor
William & Lisabeth M. Ogden
David & Nancy Remy O’Neill
Leona Oriolo
John & Lisa B. O’Rourke
Michael Orscheln
Daren & Karen R. Orzechowski
Sharon Osbourne
OSI Pharmaceuticals
Rich & Kim OToole
Alexander B. Over
Pacific Fleet Submarine
Memorial Association, Inc.
Alphonse & Patsy S. Palmer
John Patterson
Mark & Barbara Patterson
Roger & Jennifer Pearson
John Peckham
James Pelham
Mark & Stephanie L. Perezous
Nathan & Roz Perlmutter
Steven & Susan Perrins
Kim Petersen
Bruce & Sharon Peterson
Kristi Peterson
Beverly A. Pettit
Michelle Snyderman Platt
Martin Pollack
Jessica Pollner
James R. & Betty Powell
Power Marketing Partners
Piero & Marilyn Chinitz Pozzi
Greg & Lorraine Pritchard
Professional Boiler
Maintenance, Inc.
Proskauer Rose, LLP
John H. & Suzanne B. Prunier
John & Diane Prunotto
Hal Purkey
Christopher Pye
Quality Corn & Turfgrass
Gustav & Claire Raaum
Grace Rapinchuk
Reading Entertainment, LLC
James & Heidi M. Reilly
Marvin M. & Susan Reiss
Richard & Deborah Reiss
Maurice Reissman
Research & Education
Foundation
Revel Seven
Victor & Patricia Warshaw Rich
Scott & Kimberly Richbourg
Michael & Susan Richter
Larry Rick
Rio Mar Beach Resort
Anne Riskin
26
The MMRF is grateful for every donation it receives. However, due to space limitations, this list reflectsdonors who have contributed $1,000 or more.
Sarah Robbins
Robert and Jane Toll Foundation
Mr. John Roberts
Rooms To Go Central Corp.
Michele Rose
Rosenbaum Design Group
Jane L. Rosenthal
Wendy K. Ross
Martin Rostowski
Rota Portrait Studio
Steven & Hallam Roth
Jeff & Jacquie Rothe
Marc Rozman
Safeco Insurance Foundation
Robert Salerno
Paul F. Salvatore
Mike Sanders
Sav a Tree
Savoy Capital, Inc.
Kenneth Sawyer
Bill & Pam Saxelby
Richard & Linda B. Schaps
Pearl Schechter
Scherer Schneider Paulick, LLC
Mark Anthony Schiponi
Berry K. & Sheryl Schwartz
Edward Schwartz
Sheila Schwartzburg
Chris Scott
SDSS Kung Fu of Greenwich
Select Investment Realty
Advisors
Brian T. Seltzer
Semafore Pharmaceuticals, Inc.
Theodore & Sheryl Shaker
Dr. James O. Shaw, Jr.
Thomas & Linda Shortway
David & Jill Shulman
Dick & Nan Shupe
William Shutzer
Eric & Karen Siebert
Russell Siebert
Jeffrey Siegal
Lauri Sussman Siegel
Phillip & Veronica Siegel
Siena Construction Corporation
Edward A. & Kathy M. Silver
Paul & Christine Simmons
Barry & Bonnie Singer
Roger & Linda Sisterman
James A. Skinner
Nigel Skinner
Skyline Hotel, LLC
David & Cathy M. Slack
Kevin Smith
Society of Cosmetic Chemists,
NY Chapter
Soil Mechanics
Michael Sokol
Elizabeth Sandra Sondak
Peter & Marie-Regina Sotos
Jerry Spaugh
George & Claire Speen
Gianni & Clare Spera
Arthur & Constance A. Spiegel
David A. Stafman
James & Carolyn S. Stauner
Jaimie & Esta Stecher
Janet Steiner
Mary Beth Stepanek
Sterling Properties
Susan Stewart
Carl Stickel
Dale R. & Gail A. Stockamp
Michael E. Stone
Mel & Jean Stottlemyre
Bryan & Leslie Street
Angela Strick
Jackie Suarez
Lois Svard
Talbots Charitable Foundation
Tanenbaum-Harbor Co., Inc.
Mark D. Teich
David Teiger
The Capital Group Companies
Charitable Foundation
The Jerold B. Katz Foundation
The John R. Kennedy
Foundation, Inc.
The Mark Kingseed & Joan
Breitenbucher Foundation
The Ritz Carlton New York
Central Park
The Ritz Carlton South Beach
The Spine Group, Inc.
Thomas H. Lee Partners, LP
George E. & Sharon L.
Thompson
Jane Thompson
Thompson, Becker &
Bothwell, LLC
Thomson Inc.
Thrivent Financial For
Lutherans
Thunderbird Junior Golf
Foundation
David & Juliet Tibma
Jill Timmons
Hollis & Dorothy Tinsler
Terrance Tomann
Tory Burch
Kimberly Tragerman
Ulrik & Julia Trampe
Kuan Chang Tseng
Matthew J. & Sheryl K. Turk
Paul Ullman & Donna Zaccaro
U.S. Trust, Bank of America
UCONN Co-Op, Univ. of
Conn. Cooperative Corp.
Unconventional Events
John & Donna M. Underwood
Mark Urich
URS Washington Division
Jim & Joy Utts
Valerie Wilson Travel
Bonnie Valiant
Lee & Kathi Van Boven
David H. Vesole
Richard & Patricia Vesper
Vila Vita
Eric Vincent
Gregory & Maria Schuler-Vogler
George & Lynn Vos
Nancy R. Wadhams
Wagner Family Foundation
Jeffrey & Barbara Walder
Christopher & Terri Walker
Judy Walker
Peter & Theresa Warenski
Michael & Frances Waring
Washington, Pittman &
McKeever, LLC
Button Watkins
Sandra Wear
James Webb
Weed and Duryea
Steven & Carolyn B. Weiby
David J. Weiner
Rita Weissman
Anne C. Welke
Wenner Media, LLC
Westin Embassy Row
WG Trading Company Limited
Partnership
Cheryl Whitaker
Daniel & Elvira B. White
Gregory White
Thomas J. & Lois White
Nancy A. Wilcox
William Donald &
Associates, Inc.
Brian & Jane S. Williams
David & Carolyn Williams
Nicholas & Whitney Williams
Barry & Karen Wolf
John & Rita Wolf
Diane Nelson Wood
Jeffrey & Laxmi Wordham
WP Realty Inc.
Wyndham Sugar Bay Resort
Yassky Properties
Charleeton & Sandra G. Younts
Jeffrey W. Yundt
Dennis Zaslavsky
Zevenbergen Capital
Investments, LLC
George & Marianne Zorich
MMRF Annual Report 2008 27
28
MMRF Annual Report 2008 29
Multiple Myeloma Research Foundation
383 Main AvenueMerrittView – 5th Floor
Norwalk, CT 06851
Ph: (203) 229-0464Fx: (203) 229-0572
E-mail: [email protected]